Page results
-
Information for relatives following bereavement and about the role of the Medical Examiner Service at UCLH.
-
Advice on activity management for young people living with fatigue conditions.
-
This page aims to support and supplement the information provided in the video titled Managing the Emotional Impact of Cancer, available on uclh.nhs.uk/wellbeing.
-
This clinic provides a service within North Central London to children and young people up to 18 years of age with unusual, complicated or recurrent infections. A family infection clinic is also provided where family groups may be reviewed together by both adult and paediatric teams.
-
The Upper GI service provides treatment for, amongst other conditions, oesophageal and gastric cancers as well as for benign conditions (acid reflux and motility disorders). There is close collaboration with the GI physiology and laser centre.
-
Our clinical neurophysiology department performs tests which record information from the brain or the nervous system. There are two main tests performed in our outpatient department, Electroencephalogram (EEG) and Nerve conduction studies (NCS).
-
This patient information explains what Aural (ear) microsuction is and what your alternatives are.
-
Whether to check appointment details, receive test results and clinic letters, or to complete pre-visit questions and checks to prepare for appointments, more and more patients activate MyCare UCLH each day.
-
This page explains how to hand express your colostrum. It is for mothers/birthing parents who will have a baby on the neonatal unit.
-
At University College Hospital education is provided for inpatients of school age on the paediatric floor (T11) and the adolescent floor (T12).
File results
-
FOI/2022/0433 - A&E attendances with effects of heat, light and sunburn
-
FOI/2022/0437 - IT infrastructure systems used at Trust
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0448 - Electronic cloud based job evaluation system
-
FOI/2022/0449 - Use of defibrotide for the treatment of Hepatic Veno-occlusive disease
-
FOI/2022/0451 - Patient information leaflets
-
FOI/2022/0454 - Temporary staff waiting list initiative and overtime spend
-
FOI/2022/0456 - Treatment of renal cell carcinoma
-
FOI/2022/0459 - Interpreters and translation services
-
FOI/2022/0465 - Treatment of dermatological conditions